groupH provides strategic direction to companies developing and marketing innovative healthcare products. We focus on commercial analysis and decision making particular in the early stages of product development.

We’re passionate about helping these companies, because they help to change lives.

Established in 2005, we are a new generation of agency that uses a flexible business model. The core of our company have been working together for over 20 years. We also draw on a trusted network of experienced and highly-skilled individuals based in key markets to create the optimal team for each project.

You can meet the people behind the team on our team page: www.grouph.com/team

We focus on the robust assessment of commercial opportunities of novel treatments, and strategic market access topics. We find unique solutions to the many challenges our customers face including; entering new markets, launching new products and engaging in acquisition or licensing transactions. The scope of our work is global; including the US, EU and developing markets, and covers all disease areas. 

Our insight are underpinned by rigorous market analysis and commercial modelling (forecasting and valuation). In-depth primary research is also a cornerstone of our work; to better understand the issues and add ‘real-world’ insight. We work closely with our growing network of industry stakeholders such as pharmacists, nurses, physicians, surgeons, pricing specialists and payers, in all key global markets.

We continue to develop refreshing new approaches to help our clients work more confidently and efficiently, to ‘do more with less’.  We always conduct our commercial assessments to suit the particular business solutions; from quick-turnaround high level views to in-depth market modelling.

To find out more, visit our website:  www.grouph.com/

groupH

Org chart

Teams

Offices